Endocrine Testing Market is Expected to Reach USD 2.03 Billion Globally in 2019: Transparency Market Research

January 31, 2014

ALBANY, New York, January 31, 2014 /PRNewswire/ –

According to a new market report published by Transparency Market Research “Endocrine
Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin,
Cortisol, Insulin Tests and Others)- Global Industry Analysis, Size, Share, Growth, Trends
and Forecast, 2013 – 2019,” the global endocrine testing market was valued at
USD1.53billion in 2012 and is estimated to reach a market worth USD2.03 billion in 2019
growing at a CAGR of 4.3% from 2013 to 2019.

Browse Endocrine Testing Market Report with Full TOC at


Endocrine system refers to the collection of endocrine glands (ductless glands) and
secretory organs that release hormones directly into the blood stream. Endocrine system is
instrumental in regulating certain body mechanisms such as metabolism, growth and sexual
development and emotions. Also, it enables the body to cope up with different events such
as cellular mechanisms and stress by acting in co-ordination with the nervous system.
Hormones refer to the body’s chemical messengers and render information and instruction
transfer from one set of cells to another. Hormones can act only on those cells that are
genetically programmed to receive and respond to the information or instructions released
by hormones. There are lot of factors that influence the hormone levels including changes
in body fluids and minerals in blood along with stress and infection.

Several endocrine tests are performed to assess varying levels of hormones in the
body. This results in the determination of hypersecretion (excess) or hyposecretion (less)
that consequently helps in early diagnosis and treatment of several endocrine disorders
(such as sexual dysfunction, diabetes and others). Consistent rise in diabetic, obese and
infertile patient population across the globe has broadened the scope for growth and
acceptance of various endocrine test kits. In addition, introduction of technologically
advanced diagnostic platforms coupled with growing healthcare awareness and surge in
preference for quick and easy operating test platforms have further augmented the growth
prospects for endocrine test kits or methodologies. On the contrary, high development
costs and less flexible reimbursement policies are some of the factors that may hamper the
growth of global endocrine testing market.

Endocrine tests are instrumental in monitoring the normal and abnormal levels of
hormones secreted in the body. The market for insulin tests is estimated to record highest
growth rate during the forecast period majorly due to increasing incidence of the diabetes
worldwide coupled with technological advances and increasing healthcare awareness across
the globe. As per International Diabetes Federation (IDF), in the year 2013, around 382
million people suffered from diabetes and are anticipated to rise to 592 million by 2035.
Also, 80% of the diabetic population lives in low and middle income nations. Thyroid
stimulating hormone test constituted the largest market segment owing to increasing
thyroid dysfunction cases and pose high risk for acquiring cardiovascular disorders. The
increased acceptance of endocrine test kits is attributed to increasing incidence of
obesity, unhealthy food habits, physical inactivity and consistent technological advances.
Follicle stimulating hormone test followed by human chorionic Gonadotropin test occupied
third and fourth position in the market by 2019. Hence, all these factors mentioned above
influence the growth and acceptance of several test kits.

Among the diagnostic technology market the tandem mass spectrometry segment is
estimated to record highest growth rate due to high specificity and accuracy rendered by
this platform in determination of hormone levels. Immunoassays and sensor technologies are
expected to be the other fastest growing diagnostic technology segments during the
forecast period owing to their increased use in several endocrine testing methodologies.
However, high cost involved in the research and development along with subsequent
commercialization of the same results in the high costs of the tests thereby hampering the
growth of the market.

While, the ambulatory care centers of the total market, by end users segment is
expected to be the fastest growing segment during the forecast period due to quick service
offerings and costs reduction due to less hospital stay and gain competitive edge over the
other end users. In addition, home based tests and commercial laboratories are also
expected to grow considerably as compared to others (hospitals and physician offices).

At the regional level, Europe was the largest market in 2012for endocrine testing
market [http://www.transparencymarketresearch.com/endocrine-testing-market.html ] followed
by North America. The growth has been attributed to the presence of sophisticated
laboratories along with increased participation of the respective governments in these
regions. Asia-Pacific region represents the fastest growing region during the forecast
period from 2013 to 2019.This is majorly due to huge untapped patient population,
increasing healthcare awareness and healthcare spending and presence of large number of
undiagnosed and untreated patients in low and middle income nations. In addition, rise in
disposable incomes and increased investments of many key players in these emerging
economies will further boost the growth and development in this region. For instance,
Abbott Laboratories has been investing heavily in the emerging economies such as India and
China to enhance their revenues to 50% by 2015. The company has opened around six
manufacturing and R&D facilities in Asia-Pacific region. This substantiates the lucrative
business opportunities in these regions and enables the companies to introduce and
commercialize quality endocrine tests thereby enhancing the strength of the market

Related & Recently Published Reports by Transparency Market Research

        - Ophthalmic Drugs Market:


        - Life Sciences BPO Market:


        - Molecular Diagnostics Market:


        - Blood Flow Measurement Devices:


        - Building and Construction Plastics Market:


        - Organ Preservation Solutions Market:


The endocrine testing market is characterized by the presence of well-established as
well as new players solely operating in this market. The major companies competing in this
market are Agilent Technologies, F.Hoffmann La-Roche, Ltd., Abbott Laboratories and
Siemens Healthcare and DiaSorin S.p.A.

The Global endocrine testing market is segmented as follows:

        - Endocrine TestingMarket, by Test

Estradiol (E2) Test

Follicle Stimulating Hormone (FSH) Test

Human Chorionic Gonadotropin (hCG) Test

Luteinizing Hormone (LH) Test

Dehydroepiandrosterone sulfate (DHEAS) Test

Progesterone Test

Testosterone Test

Thyroid Stimulating Hormone (TSH) Test

Prolactin Test

Cortisol Test

Insulin Test

Others (Gastrin, Thymosin, Secretin, etc.)

        - Endocrine Testing Market, by Diagnostic Technologies

Tandem Mass Spectrometry

Immunoassay Technologies

Monoclonal and Polyclonal Antibody Technologies

Sensor Technologies

Clinical Chemistry Technologies


        - Endocrine Testing Market, by End Users


Commercial Laboratories

Ambulatory Care Centers

Home Based Tests

Physician Offices

        - Endocrine Testing Market, by Geography

North America



Rest of the World (RoW)

Browse all Pharmaceutical Market Research Reports @


About Us

Transparency Market Research is a global market intelligence company, providing global
business information reports and services. Our exclusive blend of quantitative forecasting
and trends analysis provides forward-looking insight for thousands of decision makers. We
are privileged with highly experienced team of Analysts, Researchers, and Consultants, who
use proprietary data sources and various tools and techniques to gather, and analyze

Our data repository is continuously updated and revised by a team of research experts,
so that it always reflects the latest trends and information. With a broad research and
analysis capability, Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research material for business

        Sheela AK
        90 Sate Street, Suite 700
        Albany, NY 12207
        Tel: +1-518-618-1030
        USA - Canada Toll Free: 866-552-3453
        Email: sales@transparencymarketresearch.com
        Web: http://www.transparencymarketresearch.com
        Blog: http://www.tmrblog.com
        Blog: http://transparencymarketresearch.areavoices.com

SOURCE http://www.transparencymarketresearch.com/

Source: PR Newswire

comments powered by Disqus